CXCL-10, IL-12 and IL-21 Are Not Immunological Predictors of HBeAg Seroconversion in HIV-1–HBV Coinfection Following HBV-active Antiretroviral Therapy (ART)
Antiviral Therapy - United Kingdom
doi 10.3851/imp2720
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
International Medical Press